Innovation Pharmaceuticals Inc (IPIX)

[oddone33320]

"The Company is currently focused on completing the Clinical Study Report for its Phase 2 clinical trial (see NCT02324335) evaluating Brilacidin’s ability to safely prevent and attenuate SOM in HNC patients receiving chemoradiation and compiling a Briefing Package for discussion with the FDA. "

Anyone know if you need to submit the CSR/Briefing Package to the FDA at the same time as your meeting request? It's been 2 weeks since the last PR where they stated the above, curious to know whether it is possible that they've had their meeting since then or if they need to finish the "Briefing Package" before the meeting request and may still be waiting on a meeting date to be scheduled.